Literature DB >> 10693921

Differential effects of corticostriatal and thalamostriatal deafferentation on expression of the glutamate transporter GLT1 in the rat striatum.

J C Liévens1, P Salin, L Had-Aissouni, N Mahy, L Kerkerian-Le Goff.   

Abstract

This study compared the effects of the disruption of the two main presumably glutamatergic striatal inputs, the corticostriatal and thalamostriatal pathways, on GLT1 expression in the rat striatum, using in situ hybridization and immunohistochemistry. Unilateral ibotenate-induced thalamic lesion produced no significant changes in striatal GLT1 mRNA labeling and immunostaining as assessed at 5 and 12 days postlesion. In contrast, significant increases in both parameters were measured after bilateral cortical lesion by superficial thermocoagulation. GLT1 mRNA levels increased predominantly in the dorsolateral part of the striatum; there, the increases were significant at 5 (+84%), 12 (+101%), and 21 (+45%) but not at 35 days postlesion. GLT1 immunostaining increased significantly and homogeneously by 17-26% at 12 and 21 days postlesion. The increase in GLT1 expression at 12 days postlesion was further confirmed by western blot analysis; in contrast, a 36% decrease in glutamate uptake activity was measured at the same time point. These data indicate that striatal GLT1 expression depends on corticostriatal but not thalamostriatal innervation. Comparison of our results with previous data showing that cortical lesion by aspiration downregulates striatal GLT1 expression further suggests that differential changes in GLT1 expression, and thus presumably in glial cell function, may occur in the target striatum depending on the way the cortical neurons degenerate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693921     DOI: 10.1046/j.1471-4159.2000.0740909.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

Review 1.  The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states.

Authors:  Yoland Smith; Dinesh Raju; Bijli Nanda; Jean-Francois Pare; Adriana Galvan; Thomas Wichmann
Journal:  Brain Res Bull       Date:  2008-09-19       Impact factor: 4.077

2.  Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.

Authors:  OrhanTansel Korkmaz; Hakan Ay; Emel Ulupinar; Neşe Tunçel
Journal:  J Mol Neurosci       Date:  2012-04-29       Impact factor: 3.444

3.  A social deafferentation hypothesis for induction of active schizophrenia.

Authors:  Ralph E Hoffman
Journal:  Schizophr Bull       Date:  2007-07-13       Impact factor: 9.306

Review 4.  Overview of Glutamatergic Dysregulation in Central Pathologies.

Authors:  Tanya Miladinovic; Mina G Nashed; Gurmit Singh
Journal:  Biomolecules       Date:  2015-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.